Related Experiment Video
Updated: Jun 14, 2025

Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates
Published on: April 22, 2019
Calcipotriol abrogates TGF-β1/pSmad3-mediated collagen 1 synthesis in pancreatic stellate cells by downregulating
Meifang Zheng1, Hongyan Li1, Li Sun1
1Department of Hepatic biliary Pancreatic Medicine, First Hospital of Jilin University, Changchun, China.
Abstract:
RUNX1 with CBFβ functions as an activator or repressor of critical mediators regulating cellular function. The aims of this study were to clarify the role of RUNX1 on regulating TGF-β1-induced COL1 synthesis and the mechanism of calcipotriol (Cal) on antagonizing COL1 synthesis in PSCs. RT-qPCR and Western Blot for determining the mRNAs and proteins of RUNX1 and COL1A1/1A2 in rat PSC line (RP-2 cell). Luciferase activities driven by RUNX1 or COL1A1 or COL1A2 promoter, co-immunoprecipitation and immunoblotting for pSmad3/RUNX1 or CBFβ/RUNX1, and knockdown or upregulation of Smad3 and RUNX1 were used. RUNX1 production was regulated by TGF-β1/pSmad3 signaling pathway in RP-2 cells. RUNX1 formed a coactivator with CBFβ in TGF-β1-treated RP-2 cells to regulate the transcriptions of COL1A1/1A2 mRNAs under a fashion of pSmad3/RUNX1/CBFβ complex. However, Cal effectively abrogated the levels of COL1A1/1A2 transcripts in TGF-β1-treated RP-2 cells by downregulating RUNX1 production and hindering the formation of pSmad3/RUNX1/CBFβ complexes. This study suggests that RUNX1 may be a promising antifibrotic target for the treatment of chronic pancreatitis.
Insights
RUNX1 activates collagen synthesis in pancreatic stellate cells via the TGF-β1/pSmad3 pathway. Calcipotriol inhibits this process by downregulating RUNX1, suggesting RUNX1 as a potential antifibrotic target for pancreatitis.
Area of Science:
- Cell Biology
- Molecular Biology
- Gastroenterology
Background:
- RUNX1, in complex with CBFβ, regulates key cellular functions.
- Transforming growth factor-beta 1 (TGF-β1) is implicated in fibrotic processes.
- Pancreatic stellate cells (PSCs) play a central role in pancreatic fibrosis.
Purpose of the Study:
- To elucidate RUNX1's role in TGF-β1-induced collagen type 1 (COL1) synthesis in PSCs.
- To investigate the mechanism by which calcipotriol (Cal) antagonizes COL1 synthesis.
- To identify potential antifibrotic therapeutic targets for chronic pancreatitis.
Main Methods:
- Quantitative real-time PCR (RT-qPCR) and Western blotting for RUNX1 and COL1A1/1A2.
- Luciferase reporter assays for promoter activity.
- Co-immunoprecipitation and immunoblotting for protein interactions (pSmad3/RUNX1, CBFβ/RUNX1).
- Gene knockdown and upregulation experiments for Smad3 and RUNX1.
Main Results:
- TGF-β1/pSmad3 signaling pathway regulates RUNX1 production in PSCs.
- RUNX1 and CBFβ form a coactivator complex (pSmad3/RUNX1/CBFβ) that drives COL1A1/1A2 transcription.
- Calcipotriol inhibits COL1A1/1A2 transcript levels by reducing RUNX1 and disrupting the pSmad3/RUNX1/CBFβ complex formation.
Conclusions:
- RUNX1 is a key regulator of TGF-β1-induced collagen synthesis in pancreatic stellate cells.
- Calcipotriol's antifibrotic effect is mediated through the downregulation of RUNX1 and its coactivator complex.
- RUNX1 represents a promising antifibrotic therapeutic target for chronic pancreatitis.
Related Concept Videos
TGF - β Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway

